"10.1371_journal.pone.0119980","plos one","2015-03-17T00:00:00Z","Bruna Gigante; Rona J Strawbridge; Ilais Moreno Velasquez; Zahra Golabkesh; Angela Silveira; Anuj Goel; Damiano Baldassarre; Fabrizio Veglia; Elena Tremoli; Robert Clarke; Hugh Watkins; Anders Hamsten; Steve E Humphries; Ulf de Faire","Unit of Cardiovascular Epidemiology, Institute of Environmental Medicine (IMM), Stockholm, Sweden; Division of Cardiovascular Medicine, Department of Clinical Sciences, Danderyd University Hospital, Stockholm, Sweden; Cardiovascular Genetics and Genomics Group, Atherosclerosis Research Unit, Department of Medicine Solna, all at Karolinska Institutet, Stockholm, Sweden; Department of Cardiovascular Medicine, The Wellcome Trust Centre of Human Genetics, University of Oxford, Oxford, United Kingdom; Dipartimento di Scienze Farmacologiche e Biomolecolari, Universit√† di Milano, Milan, Italy; Centro Cardiologico Monzino, IRCCS, Milan Italy; Clinical Trial Service Unit, University of Oxford, Oxford, United Kingdom; Dept of Cardiology, Karolinska University Hospital, Stockholm, Sweden; Centre for Cardiovascular Genetics, University College London, United Kingdom","Conceived and designed the experiments: BG RJS UdF. Performed the experiments: BG IM ZG AG AS DB FV. Analyzed the data: BG RJS. Contributed reagents/materials/analysis tools: ET SEH HW RC AH. Wrote the paper: BG RJS AH SEH UdF.","The authors of this manuscript have read the journals policy and have the following competing interests: The PROCARDIS study was supported by AstraZeneca, a commercial biopharmaceutical company. This funder played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors adherence to PLOS policies on sharing data and materials.","2015","03","Bruna Gigante","BG",14,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
